|
|
||||||||
Eur J Cardiothorac Surg 1999;15:401-407
© 1999 Elsevier Science NL
a Department of Cardiac Surgery, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany
b The Cleveland Clinic Foundation, Department of Thoracic and Cardiovascular Surgery, Cleveland, OH, USA
c Department of Biostatistics and Epidemiology, Cleveland, OH, USA
Received 21 September 1998; received in revised form 7 January 1999; accepted 12 January 1999.
Corresponding author. Tel.: +49-6221-564-398; fax: +49-6221-565-585; e-mail: brigitte.osswald@med.uni-heidelberg.de
Objective: Investigations of early mortality after coronary artery bypass grafting (CABG) are predominantly based on 30-day mortality or hospital mortality. The advantages, disadvantages, and usefulness of hospital mortality and 30-day mortality analyses to investigate the early risk after CABG are evaluated. Methods: A total of 4985 patients underwent isolated CABG from June 1988 to June 1997. A follow-up was performed 180 days after CABG (response rate: 98.6%). Results: The mean hospital stay was 13.5±9.6 days, the range was 0 to 142 days (25% quartile, 9 days; median, 12 days; 75% quartile, 15 days). The hospital mortality was 5.3%. The 30-day mortality was 5.6%. The non-parametric KaplanMeier curve of the time interval 0180 days postoperatively proves the persistence of the still decreasing behaviour of the survival curve beyond the 30th day until about the 60th postoperative day. Stratified by era of operation, the `early phase' after CABG seems to be prolonged beyond 30 days at least for the more recent operation era since 1991. Risk stratification proves that the higher the risk group, the more the early phase tends towards a prolongation. Conclusions: The hospital mortality reflects institutional habits concerning postoperative patient care. Therefore, a systematic underestimation of early mortality is likely. In contrast to hospital stay, the evaluation of 30-day mortality requires a follow-up procedure but allows interinstitutional comparisons. Nevertheless, 30-day mortality systematically underestimates the early risk, at least in the more recent CABG period. So, a standardized evaluation of a longer time period (p.e. 180 days) is recommended.
Key Words: Early mortality Coronary artery bypass grafting Risk analysis
This article has been cited by other articles:
![]() |
A. Parolari, L. L. Pesce, M. Trezzi, C. Loardi, S. Kassem, C. Brambillasca, B. Miguel, E. Tremoli, P. Biglioli, and F. Alamanni Performance of EuroSCORE in CABG and off-pump coronary artery bypass grafting: single institution experience and meta-analysis Eur. Heart J., February 1, 2009; 30(3): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Rice and E. H. Blackstone Esophagectomy volume threshold as a criterion for centers of excellence: causation or cause, strategy or strategem? J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 10 - 12. [Full Text] [PDF] |
||||
![]() |
L. Noyez, F. W.A. Verheugt, and H. A. van Swieten The importance of an organized follow-up for the evaluation of mortality after hospital discharge in cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 449 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staudinger, H. Ostermann, G. Laufer, R. Schistek, B. Staudinger, and B. Tilg Evaluation of cardiac scoring models for an Austrian cardiac register Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 470 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Bhudia, P. M. McCarthy, G. S. Kumpati, J. Helou, K. J. Hoercher, J. Rajeswaran, and E. H. Blackstone Improved Outcomes After Aortic Valve Surgery for Chronic Aortic Regurgitation With Severe Left Ventricular Dysfunction J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1465 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shahian, T. Silverstein, A. F. Lovett, R. E. Wolf, and S.-L. T. Normand Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards Circulation, March 27, 2007; 115(12): 1518 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Florath, A. Albert, W. Hassanein, B. Arnrich, U. Rosendahl, I. C. Ennker, and J. Ennker Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 716 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. DeSimone and P. Sergeant Off-pump myocardial revascularization MMCTS, October 9, 2006; 2006(1009): 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Likosky, W. C. Nugent, R. A. Clough, P. W. Weldner, H. B. Quinton, C. S. Ross, and G. T. O'Connor Comparison of Three Measurements of Cardiac Surgery Mortality for the Northern New England Cardiovascular Disease Study Group Ann. Thorac. Surg., April 1, 2006; 81(4): 1393 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fung, R. R. Fiscus, A. P. C. Yim, G. D. Angelini, and A. A. Arifi The Potential Use of Type-5 Phosphodiesterase Inhibitors in Coronary Artery Bypass Graft Surgery Chest, October 1, 2005; 128(4): 3065 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jin, G. L. Grunkemeier, and For the Providence Health System Cardiovascular St Additive vs. logistic risk models for cardiac surgery mortality Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 240 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shahian, E. H. Blackstone, F. H. Edwards, F. L. Grover, G. L. Grunkemeier, D. C. Naftel, S. A.M. Nashef, W. C. Nugent, and E. D. Peterson Cardiac Surgery Risk Models: A Position Article Ann. Thorac. Surg., November 1, 2004; 78(5): 1868 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Wouters and L. Noyez Is no news good news? Organized follow-up, an absolute necessity for the evaluation of myocardial revascularization Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 667 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karthik, A. K. Srinivasan, A. D. Grayson, M. Jackson, D. A.C. Sharpe, D. J.M. Keenan, B. Bridgewater, and B. M. Fabri Limitations of additive EuroSCORE for measuring risk stratified mortality in combined coronary and valve surgery{star} Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 318 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pinna Pintor, S. Colangelo, and M. Bobbio Evolution of case-mix in heart surgery: from mortality risk to complication risk Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 927 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. van Eck, L. Noyez, F. W.A. Verheugt, and R. M.H.J. Brouwer Analysis of mortality within the first six months after coronary reoperation Ann. Thorac. Surg., December 1, 2002; 74(6): 2106 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sergeant, E. de Worm, and B. Meyns Single centre, single domain validation of the EuroSCORE on a consecutive sample of primary and repeat CABG Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sergeant, E. de Worm, B. Meyns, and P. Wouters The challenge of departmental quality control in the reengineering towards off-pump coronary artery bypass grafting Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Sergeant and E. H. Blackstone Closing the loop: optimizing physicians’ operational and strategic behavior Ann. Thorac. Surg., August 1, 1999; 68(2): 362 - 366. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |